Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Central Nervous System Neoplasms × Vinblastine × 90 days × Clear all

Sponsor

Conditions

Hodgkin Disease 5 Urinary Bladder Neoplasms 2 Renal Pelvis and Ureter Urothelial Carcinoma 1 Neoplasms 1 Lymphoma 1 Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1 Carcinoma, Transitional Cell 1

Interventions

Magnetic Resonance Spectroscopy 5 Biopsy 4 X-Rays 3 Specimen Handling 3 Phantoms, Imaging 3 Nuclear Medicine Department, Hospital 3 selpercatinib 2 erdafitinib 2 entrectinib 2 ensartinib 2 Radiotherapy 2 Nivolumab 2 Lomustine 2 Etoposide 2 Cyclophosphamide 2 Carboplatin 2 ulixertinib 1 tipifarnib 1 tazemetostat 1 regorafenib 1 perillyl alcohol 1 pemigatinib 1 pembrolizumab 1 pegfilgrastim 1 palbociclib 1 olaparib 1 niraparib 1 lenvatinib 1 larotrectinib 1 ivosidenib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡